Total
0
Shares
Little Green Pharma (ASX:LGP) - Managing Director, Fleta Solomon - The Market Herald
Managing Director, Fleta Solomon
Source: AUManufacturing
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Little Green Pharma (LGP) has opened its share purchase plan (SPP) with aims to raise up to $5 million
  • Under the plan, eligible shareholders will be able to subscribe for up to $30,000 worth of shares, which are priced at 65 cents
  • This price represents a 17.3 per cent discount to the five-day volume-weighted average price
  • LGP will use the money to speed-up sales and marketing efforts in both Australia and overseas as well as expand its manufacturing capacity
  • Shares in Little Green Pharma have dropped 8.75 per cent and are trading at 73 cents each

Little Green Pharma (LGP) has opened its share purchase plan (SPP) with aims to raise up to $5 million.

This follows on from a recently announced placement to sophisticated, experienced and professional investors to raise $22 million.

All up, around 34 million shares were issued to participants at 65 cents.

Under the SPP, eligible shareholders will be able to subscribe for up to $30,000 worth of shares, which are also priced at 65 cents.

This price represents a 17.3 per cent discount to the five-day volume-weighted average price.

The company's Australian-based Directors, Angus Caithness and Neale Fong, intend to apply for the maximum $30,000 worth.

In the event of oversubscriptions, LGP has the right to scale-back applications.

LGP will use the money from both the placement and share purchase plan to speed-up sales and marketing efforts in both Australian and overseas markets, and expand its manufacturing and cultivation capacity.

The plan is set to close on March 3 and shares will be issued on March 11 and begin trading on the ASX on March 12.

Shares in Little Green Pharma have dropped 8.75 per cent and are trading at 73 cents each at 1:56 pm AEDT.

LGP by the numbers
More From The Market Herald
Creso Pharma (ASX:CPH) - Creso Pharma - The Market Herald

" Creso Pharma (ASX:CPH) launches ecommerce channels, enters Polish markets

Creso Pharma (CPH) has launched new e-commerce channels and expanded into Poland with a maiden purchase order secured.
Emyria (ASX:EMD) contracts consultant for psychedelics and MDMA research

" Emyria (ASX:EMD) contracts consultant for psychedelics and MDMA research

Emyria (EMD) has appointed a consultant to support its psychedelic-assisted therapy programs.
AnteoTech (ASX:ADO) - CEO, Derek Thomson - The Market Herald

" AnteoTech (ASX:ADO) ticks off another distribution deal for EuGeni

AnteoTech (ADO) has signed a distribution agreement with Ramma Dental for its EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT).
Healthia (ASX:HLA) - CEO, Wesley Coote - The Market Herald

" Healthia (ASX:HLA) up on Rothwell Physiotherapy buy

Healthia (HLA) shares have enjoyed a 10 per cent rise after reporting a $1.62 million acquisition of Queensland’s Rothwell Physiotherapy.